Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 6Lung Neoplasms 5Pancreatic Neoplasms 4Breast Neoplasms 4Biliary Tract Neoplasms 4Recurrence 3Neoplasm, Residual 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Nevi and Melanomas 2Neoplasms 2Melanoma 2Disease 2Cholangiocarcinoma 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Smoking 1Prostatic Neoplasms 1Papillomavirus Infections 1Pancreatitis, Chronic 1Pancreatic Intraductal Neoplasms 1Neurofibrosarcoma 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1NSCLC 1Multiple Myeloma 1

Interventions

pembrolizumab 1osimertinib 1icotinib 1dacomitinib 1camrelizumab 1Radiofrequency Ablation 1Microphysiological Systems 1Liquid Biopsy 1Gefitinib 1Erlotinib Hydrochloride 1Bevacizumab 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × NSCLC × Liquid Biopsy × Clear all
NCT03073902 2018-12-28

The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.

Xinqiao Hospital of Chongqing

Completed
80 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡